Final Up to date on September 1, 2026 3:38 pm by INDIAN AWAAZ
SHOBHA SHUKLA, BOBBY RAMAKANT
A 20-hospital, 3-year ICMR research of over 150,000 sufferers finds that carbapenem drug-resistant infections are driving up each deaths and remedy prices
A big multi-centre research of over 150,000 sufferers in India’s 20 tertiary-care hospitals has put a stark quantity on one of many high ten international well being threats at the moment: Antimicrobial Resistance (AMR). AMR occurs when infections simpler to deal with earlier turn out to be tough (or not possible) to deal with attributable to disease-causing microbe (similar to micro organism, virus, fungi, parasite) turning into drug resistant.
The findings supply one of many clearest multi-centre photos but of the scientific and financial burden when widespread Gram-negative micro organism turn out to be proof against carbapenem antibiotics.
And the message is blunt: AMR just isn’t merely making infections tougher to deal with. It’s translating into extra deaths and considerably greater remedy prices.
Researchers in contrast outcomes amongst sufferers contaminated with 4 main Gram-negative pathogens – Escherichia coli (E. coli), Klebsiella pneumoniae (Ok. pneumoniae), Acinetobacter baumannii (A. baumannii) and Pseudomonas aeruginosa (P. aeruginosa) – wanting particularly at infections that had been drug-resistant or inclined to carbapenem antibiotics. Carbapenem antibiotics are a robust group of broad-spectrum antibiotics, upon which clinicians have historically relied on when infections brought on by Gram-negative micro organism turn out to be proof against different medicine. Resistance to those medicines due to this fact leaves medical doctors with fewer therapeutic choices.
E. coli is a standard explanation for urinary and bloodstream infections; Ok. pneumoniae may cause pneumonia, urinary infections and sepsis; A. baumannii is especially related to critically in poor health hospital sufferers; and P. aeruginosa may cause extreme infections in folks with extended hospital publicity or underlying sickness.
The research authored by Dr Kamini Walia, Dr Sonam Vijay, Dr Nitin Bansal, et al, printed in The Lancet Regional Health – Southeast Asia (Volume 53, October 2026), analysed information from 20 tertiary-care hospitals throughout India between April 2022 and April 2025. Dr Kamini Walia serves as a senior scientist at Indian Council of Medical Analysis (ICMR), heads its Descriptive Analysis Division and leads ICMR on Antimicrobial Resistance (AMR).
Every of the 20 collaborating hospitals was required to designate a minimal of 150 inpatient beds for Antimicrobial Resistance (AMR) surveillance actions, together with a minimum of 50 intensive care unit (ICU) beds and 100 ward beds.
“All sufferers had been adopted up till their last scientific end result (discharge from the hospital or dying),” notes the research.
“Carbapenem drug-resistant infections induced considerably greater mortality and remedy prices than inclined infections. Mortality was significantly excessive in bloodstream infections, reaching 46–51% for carbapenem drug-resistant Acinetobacter, Pseudomonas and Klebsiella,” posted Dr Kamini Walia on LinkedIn. “For India, the research highlights the necessity to transfer past drug resistance surveillance to built-in surveillance linking AMR with affected person outcomes, whereas strengthening an infection prevention, proper and well timed diagnostics, antimicrobial stewardship and entry to efficient newer antibiotics.”
A nationwide snapshot of a rising risk
The dimensions of the surveillance effort is critical.
Researchers examined data from 159,336 hospitalised sufferers within the 20 tertiary-care hospitals, representing greater than 1.75 million patient-days of hospital care. “Affected person-days” measures the overall variety of days all admitted sufferers spend in a hospital or healthcare facility over a selected interval.
Of those sufferers, 27,283 had infections confirmed microbiologically, whereas 26,213 (16.4% of the whole hospitalised inhabitants studied) had Gram-negative bacterial infections.
Amongst these with Gram-negative infections, greater than six in ten had been proof against carbapenem antibiotics, based on the research’s evaluation.
Mortality rose throughout all 4 micro organism
For each main pathogen examined, sufferers with carbapenem drug-resistant infections confronted a better danger of dying than these contaminated with carbapenem inclined strains.
The distinction was significantly hanging for E. coli and P. aeruginosa. Sufferers with carbapenem-resistant E. coli had a 41% greater relative danger of dying than these with inclined infections. For P. aeruginosa, the corresponding enhance was 43%.
For Ok. pneumoniae, the relative danger was 33% greater, whereas carbapenem-resistant A. baumannii was related to a 16% greater relative danger.
Absolute mortality information underline the severity
In response to the research’s reported outcomes, mortality was 24.4% for carbapenem-resistant E. coli in contrast with 17.3% for inclined infections. For Ok. pneumoniae, mortality was 31.2% versus 23.5%. A. baumannii had significantly excessive mortality general: 37.9% amongst resistant infections in contrast with 32.8% amongst inclined infections. For P. aeruginosa, the corresponding figures had been 28.9% and 20.2%.
You will need to notice that bloodstream infections can quickly progress to sepsis and multi-organ failure, leaving little room for delays or ineffective remedy. Probably the most alarming information appeared in bloodstream infections brought on by carbapenem drug-resistant non-fermenting micro organism, principally A. baumannii and P. aeruginosa. Mortality in these instances reached 46% to 51%.
AMR additionally comes with a monetary penalty
The research didn’t cease at mortality.
Researchers additionally examined size of hospitalisation and antibiotic remedy prices. Drug-resistant infections required dearer remedy, with antibiotic prices 1.1 to 2 instances greater than these related to inclined infections.
As soon as first-line or generally used antibiotics now not work, clinicians might have newer, dearer medicine or combos of antibiotics. Sufferers might also require longer hospital stays, intensive monitoring and extra advanced (and could also be dearer) care.
For hospitals already working beneath strain, these prices accumulate rapidly.
The research discovered, for instance, that sufferers with carbapenem-resistant E. coli had a mean hospital keep of about 23 days, in contrast with about 18 days amongst sufferers with inclined E. coli infections. Nevertheless, size of hospital keep was carbapenem-resistant A. baumannii and P. aeruginosa was shorter, which may very well be due to excessive mortality. “This paradox probably displays the early mortality in carbapenem-resistant A. baumannii and P. aeruginosa infections, resulting in decreased size of hospital keep owing to poor survival,” notes the research.
In different phrases, drug resistance can create a vicious cycle: the an infection turns into tougher to deal with, remedy turns into extra difficult, hospitalisation can turn out to be longer, and prices rise whereas the affected person’s danger of dying will increase.
The altering antibiotic arsenal
The researchers additionally checked out how clinicians had been treating drug-resistant infections.
For carbapenem-resistant E. coli and Ok. pneumoniae, ceftazidime–avibactam was used extra generally than polymyxin B, reflecting the altering therapeutic panorama for difficult-to-treat Gram-negative infections.
However the availability of newer antibiotics doesn’t get rid of the underlying drawback.
Each new antibiotic launched into scientific follow exists inside an evolutionary contest. Micro organism that survive publicity can purchase or choose for resistance mechanisms, doubtlessly eroding the usefulness of medication that had been as soon as thought-about dependable.
That makes antimicrobial stewardship – the trouble to make sure antimicrobials (like antibiotics, antivirals, antifungals and anti-parasitics) are used solely when acceptable, and that, after proper and well timed analysis, the fitting drug is given on the proper dose and for the fitting period. This isn’t merely a prescribing precept however turns into a central a part of preserving the effectiveness of the remaining remedy choices.
Why well being surveillance is indispensable
A lot of the obtainable proof on AMR comes from laboratory surveillance, which may present whether or not micro organism remoted from sufferers are proof against explicit antibiotics. However understanding that drug resistance exists is totally different from understanding what it does to sufferers in real-life hospital settings throughout a various nation like India.
The brand new research hyperlinks microbiological drug resistance to outcomes similar to mortality, hospitalisation and remedy prices throughout a big multi-centre inhabitants.
That distinction is essential in India, the place researchers have pointed to fragmented surveillance, incomplete laboratory and scientific information and an absence of standardised estimates of mortality related to resistant infections.
Was an infection acquired within the healthcare facility?
The research discovered that 85% of E. coli infections had been healthcare-associated infections (or hospital acquired), 91.6% of Ok. pneumoniae infections had been healthcare-associated, 95.1% of A. baumannii infections had been healthcare-associated, and 91.9% of P. aeruginosa infections had been healthcare related. “Amongst blood stream related infections throughout all pathogens, once more majority (greater than 85%) had been categorized as healthcare-associated infections,” notes the research.
These findings level past antibiotic prescribing alone.
“Microbiologically confirmed infections had been categorized as community-acquired if the tradition was constructive inside 48 hours of hospitalisation and there was no historical past of hospitalisation throughout the previous 90 days. Infections not assembly these standards had been categorized as healthcare-associated infections,” research authors clarify.
An infection prevention as vital as new antibiotics
If drug-resistant infections are concentrated in healthcare settings, then stopping them within the first place turns into as vital as discovering higher medicine to deal with them.
The researchers finally name for stronger surveillance, higher an infection prevention and management, improved entry to efficient therapies and stronger antimicrobial stewardship.
The implications prolong from intensive-care models to hospital laboratories and pharmacy departments.
Hand hygiene, environmental cleansing, acceptable use of invasive gadgets utilized in medical procedures, speedy identification of drug-resistant organisms (proper and well timed analysis and drug-susceptibility testing the place attainable), isolation or cohorting the place acceptable, and cautious antibiotic prescribing, all kind a part of the efforts to save lots of us from drug-resistant infections.
So does well being surveillance.
A hospital can’t successfully management a drug-resistant organism it can’t detect or observe. Authorities of India’s prestigious Indian Council of Medical Analysis (ICMR)’s AMR Surveillance Programme led by Dr Kamini Walia has made pathbreaking contributions through the years to establish patterns and measure whether or not AMR interventions are working.
The brand new multi-year research was itself funded by way of an ICMR task-force undertaking.
A warning, not a verdict
The findings are highly effective, however they shouldn’t be learn as proof that drug resistance alone induced each dying.
Individuals with drug-resistant infections could differ from these with inclined infections in vital methods, together with underlying illness, severity of sickness, prior antibiotic publicity and healthcare-associated danger elements. These variations can affect outcomes independently of drug resistance itself.
The researchers’ comparability nonetheless offers robust proof of an affiliation between carbapenem drug resistance and worse outcomes throughout a number of main pathogens.
And the consistency is tough to disregard.
The research authors observe: “A lot of the hospitals, included within the research have very excessive requirements of an infection management and are accredited by nationwide and worldwide high quality management boards, however they’re tertiary care hospitals, which predominantly handle referred and critically in poor health sufferers; due to this fact, the charges noticed shouldn’t be interpreted as indicators of hospital efficiency. We suspect that hospitals with poor laboratory help to facilitate well timed identification and remedy could have far worse affected person outcomes in contrast to what’s documented on this research.”
For the well being system, this research is one other reminder that stopping drug-resistance – and stopping infections from spreading within the first place – could finally be far more cost effective than making an attempt to outrun micro organism after drug-resistance has emerged.
“Lastly, enhancing entry to newer efficient antimicrobials, is essential to scale back mortality related to drug resistant infections in India,” advocate research authors.
ICMR researcher Dr Sonam Vijay rightly shared on LinkedIn that “Our findings amongst 1.5 lakh (150,000) hospitalised sufferers, together with 16.4% with Gram-negative bacterial infections, spotlight the necessity for well timed diagnostics and entry to efficient, reasonably priced novel antimicrobials to enhance outcomes and cut back the financial burden of carbapenem-resistant infections.”
– CNS
